Matches in Wikidata for { <http://www.wikidata.org/entity/Q90637229> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q90637229 description "article scientifique publié en 2018" @default.
- Q90637229 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90637229 description "scientific article published on 01 December 2018" @default.
- Q90637229 description "wetenschappelijk artikel" @default.
- Q90637229 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90637229 name "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 name "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 type Item @default.
- Q90637229 label "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 label "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 prefLabel "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 prefLabel "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 P1433 Q90637229-9889F577-7BB4-44BC-82D9-F817044BD042 @default.
- Q90637229 P1476 Q90637229-26CA0A6F-DDC8-428C-B6B7-EB9FECAE41CC @default.
- Q90637229 P2093 Q90637229-0428D753-3660-4A76-B204-2EAAFDADB296 @default.
- Q90637229 P2093 Q90637229-A37059EA-237A-418D-B3E3-77435D3AC6F3 @default.
- Q90637229 P2093 Q90637229-E854F9E6-18E1-4A87-9823-51837560FBF4 @default.
- Q90637229 P304 Q90637229-1EEA1B4A-34B4-4F9D-B45A-C5DDA994E31B @default.
- Q90637229 P31 Q90637229-898DA7E3-0BF4-4A3F-8498-AD4E0C7BE587 @default.
- Q90637229 P356 Q90637229-04BA967D-B217-44EF-AF9E-FAB55EC16A66 @default.
- Q90637229 P433 Q90637229-B8DAF0B5-92F3-4D63-BBEF-F4BE508F898F @default.
- Q90637229 P478 Q90637229-D2AA1439-F048-41D5-AE4E-A8D1DE84372E @default.
- Q90637229 P577 Q90637229-6CDF6A0D-3E39-463B-99A9-5EAFE8286735 @default.
- Q90637229 P698 Q90637229-F22ADA28-795F-4113-9EC9-C5B34B529D76 @default.
- Q90637229 P921 Q90637229-1ED8AA50-327D-4758-92B7-26891659121F @default.
- Q90637229 P356 23258160-20181203-01 @default.
- Q90637229 P698 30566697 @default.
- Q90637229 P1433 Q27724588 @default.
- Q90637229 P1476 "Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System" @default.
- Q90637229 P2093 "Brenda Zhou" @default.
- Q90637229 P2093 "Charles C Wykoff" @default.
- Q90637229 P2093 "Seenu M Hariprasad" @default.
- Q90637229 P304 "913-917" @default.
- Q90637229 P31 Q13442814 @default.
- Q90637229 P356 "10.3928/23258160-20181203-01" @default.
- Q90637229 P433 "12" @default.
- Q90637229 P478 "49" @default.
- Q90637229 P577 "2018-12-01T00:00:00Z" @default.
- Q90637229 P698 "30566697" @default.
- Q90637229 P921 Q27429789 @default.